Skip to main content

Eric Topol, MD

Chair

Department of Translational Medicine

Chair, Department of Translational Medicine; Director & Founder, Scripps Research Translational Institute; Senior Consultant, Scripps Clinic, Division of Cardiovascular Diseases; The Gary and Mary West Chair of Innovative Medicine

Eric Topol, MD

Research Focus

Eric Topol is the Executive Vice-President of Scripps Research, the largest non-profit biomedical research in the United States, where he is founder and director of the Scripps Research Translational Institute in 2007. Clinically active as a cardiologist, he previously led Cleveland Clinic cardiology to become the leading heart center in the US. He was the founder of a new medical school at Cleveland Clinic (Lerner College of Medicine), was commissioned by the UK government to lead a review of their National Health Service. Topol is a principal investigator of two large NIH grants for innovations to promote human health. He has published over 1,300 peer-reviewed articles, with more than 380,000 citations, elected to the National Academy of Medicine, and is one of the top 10 most cited researchers in medicine. In 2024, Topol was featured in the inaugural TIME100 Health list of most influential people in health in the world. In 2025, he was voted as one of the 25 Best Leaders in the United States (US News).

He has authored four bestseller books on the future of medicine: The Creative Destruction of Medicine, The Patient Will See You Now, and Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again and his new book, Super Agers: An Evidence-Based Approach to Longevity. At Substack, he publishes Ground Truths, a weekly newsletter and podcast on cutting edge biomedical advances.


Links

Scripps Research Translational Institute

Twitter Feed: @EricTopol

Substack - Ground Truths

News

Scripps Research scientists launch new digital clinical trial to test repurposed drug for long COVID symptom relief

Study will investigate whether a GIP/GLP-1 dual receptor agonist, currently approved for type 2 diabetes, obesity and obstructive sleep apnea, can reduce symptoms of long COVID.

Read More
Scripps Research scientists launch new digital clinical trial to test repurposed drug for long COVID symptom relief

Select Publications


  • Topol, Eric J. High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine 2019, 25, 44-56.

    View
  • Topol, Eric Deep Medicine. 2019.

    View
  • Rajpurkar, Pranav; Chen, Emma; Banerjee, Oishi; Topol, Eric J. AI in health and medicine. 2022, 28, 31-38.

    View
  • Acosta, Juliá N.; Falcone, Guido J.; Rajpurkar, Pranav; Topol, Eric J. Multimodal biomedical AI. 2022, 28, 1773-1784.

    View
  • Krishnan, Rayan; Rajpurkar, Pranav; Topol, Eric J. Self-supervised learning in medicine and healthcare. 2022, 6, 1346-1352.

    View
  • Moor, Michael; Banerjee, Oishi; Abad, Zahra Shakeri Hossein; Krumholz, Harlan M.; Leskovec, Jure; Topol, Eric J.; Rajpurkar, Pranav Foundation models for generalist medical artificial intelligence. 2023, 616, 259-265.

    View
Groundbreaking Science.
Life-changing Medicine.